We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Green Light Laser Treats Benign Prostatic Hyperplasia

By HospiMedica International staff writers
Posted on 11 May 2010
GreenLight Enucleation of the Prostate (GreenLEP), instead of vaporizing the tissue, reduces the treatment period and costs for mid-size to large prostate adenomas. More...


The GreenLEP procedure involves enucleating the tissue with minimal bleeding, rather than vaporizing it, and then morcellating it. The GreenLEP set consists of a resectoscope, a special morce-scope, and a tissue morcellator, which suctions the enucleated tissue in the bladder, before shredding and extracting tissue pieces into a collection container, where the tissue chips can undergo subsequent histological examination. The photoselective vaporization technique with the GreenLight laser has shown excellent intraoperative safety even for patients taking anticoagulants. In direct ablation of tissue, the system achieves functional results comparable with the gold standard for treating benign prostatic hyperplasia (BPH), trans-urethral resection of the prostate (TURP).

The components of the system are intercompatible with other products in the range, and can also be used with video systems from other manufacturers. The three application instruments developed specifically for the GreenLight fiber can be optimized for the individual operating technique of the surgeon. Optimum irrigation conditions with 50% inlet and 50% outlet, and laser guidance without vibration are available in each instrument, allowing the retraction of the fiber into the sheath and preventing possible destruction of the telescope and protective sheath. The GreenLight Laser and the proprietary application instruments are products of Richard Wolf (Knittlingen, Germany).

"Vaporization of the prostate using the GreenLight Laser has become a standard treatment in many hospitals. I felt that although vaporization could be used to treat large adenomas, too many fibers were required,” said urologist Fernando Gómez Sancha, M.D., of the Instituto de Cirugía Urológica Avanzada (ICUA; Madrid, Spain), who developed the new procedure. "This entailed longer surgical times and higher costs, and the results of alternative therapies, such as treatment with the HoLEP Laser were still difficult to achieve. Enucleation using the GreenLight Laser permitted complete treatment of adenomatous tissue.”

Related Links:
Richard Wolf


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
ow Frequency Pulse Massager
ET10 L
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.